Delivery Order SPE2DX22D0010-SPE2D826FBJ65
Award Date 11/28/25
Potential Completion Date 12/1/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vyvanse capsules 40mg, with a ceiling value of $21,361.13. This is a firm fixed price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Vyvanse capsules 40mg, valued at approximately $25.9K. This non-competitive delivery order, with a firm fixed price structure, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $22,109.59 firm fixed-price delivery order on November 17, 2025, for the supply of Vyvanse 40mg capsules, with an ultimate completion date of November 18, 2025. This non-set-aside contract was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp serves as a critical vendor for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $29,703.35 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules 40mg. The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a non-competitive, direct order under an existing contract vehicle. This delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Vyvanse capsules (30mg) with a ceiling value of $12,867.14. This firm fixed-price delivery order, with an ultimate completion date of December 22, 2025, represents a competitively awarded contract without set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vyvanse capsules (50mg) valued at $21,014.83. This competitively awarded, firm fixed-price delivery order is set to be completed by November 6, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vyvanse capsules 40mg, with a contract ceiling value of $26,971.65 and an ultimate completion date of October 28, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.07 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) on November 20, 2025, with completion scheduled for November 21, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,095.46 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (50mg). This non-competitive, firm fixed-price delivery order is scheduled for completion by December 12, 2025, with the awardee's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...